Association of Metabolic Risk Factors With Risks of Cancer and All‐Cause Mortality in Patients With Chronic Hepatitis B-Reference-Cited by-同舟云学术

Association of Metabolic Risk Factors With Risks of Cancer and All‐Cause Mortality in Patients With Chronic Hepatitis B

Published:2021-04-19 Issue:6 Volume:73 Page:2266-2277
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lee Yun Bin¹^ORCID,Moon Hyemi²,Lee Jeong‐Hoon¹^ORCID,Cho Eun Ju¹^ORCID,Yu Su Jong¹^ORCID,Kim Yoon Jun¹^ORCID,Zoulim Fabien³,Lee Juneyoung²⁴,Yoon Jung‐Hwan¹^ORCID

Affiliation:

1. Department of Internal Medicine and Liver Research Institute Seoul National University College of Medicine Seoul Korea

2. Department of Biostatistics College of Medicine Korea University Seoul Korea

3. Cancer Research Centre of LyonINSERM U1052Lyon University Hospices Civils de Lyon, Lyon France

4. BK21 FOUR R&E Center for Learning Health Systems Korea University Seoul Korea

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31612

Reference44 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

2. Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

3. Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B

4. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

5. Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease;Cancer;2024-09-06

2. A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B;Journal of Hepatology;2024-08

3. Association of modifiable metabolic risk factors and lifestyle with all-cause mortality in patients with hepatocellular carcinoma;Scientific Reports;2024-07-04

4. Metabolic dysfunction-associated fatty liver disease increases the risk of type 2 diabetes mellitus in young Korean adults;Diabetes Research and Clinical Practice;2024-06

5. MASLD/MetALD and mortality in individuals with any cardio-metabolic risk factor: A population-based study with 26.7 years of follow-up;Hepatology;2024-05-13